Details for Patent: 7,547,452
✉ Email this page to a colleague
Summary for Patent: 7,547,452
Title: | Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
Abstract: | Sustained-release microparticle composition. The microparticle composition can be formulated to provide extended release over a period of from about 7 days to about 200 days. The microparticles may be formulated with a biodegradable and biocompatible polymer, and an active agent, such as risperidone, 9-hydroxy-risperidone, and pharmaceutically acceptable acid addition salts of the foregoing. |
Inventor(s): | Atkins; Thomas J. (York, PA), Rickey; Michael E. (Loveland, OH), Mesens; Jean (Wechelderzande, BE) |
Assignee: | Alkermes, Inc. (Cambridge, MA) Janssen Pharmaceutica, N.V (Beerse, BE) |
Application Number: | 11/826,384 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 7,547,452
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,547,452
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 288270 | ⤷ Try a Trial | |||
Australia | 694147 | ⤷ Try a Trial | |||
Australia | 8142594 | ⤷ Try a Trial | |||
Bulgaria | 100632 | ⤷ Try a Trial | |||
Bulgaria | 63246 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |